Local consolidative therapy in oligometastatic non-small-cell lung cancer after effective systemic treatment: who will benefit?
Saved in:
| Main Authors: | Jiayi Deng, Mingyi Yang, Qing Zhou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
China Anti-Cancer Association
2025-01-01
|
| Series: | Cancer Biology & Medicine |
| Online Access: | https://www.cancerbiomed.org/content/22/1/21 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of radiotherapy in the treatment of oligometastatic non-small cell lung cancer
by: Radovan Vojtišek
Published: (2025-01-01) -
A Call for the Aggressive Treatment of Oligometastatic and Oligo-Recurrent Non-Small Cell Lung Cancer
by: Pretesh R. Patel, et al.
Published: (2012-01-01) -
Early local therapy in combination with PD-1/PD-L1 inhibitors in oligometastatic non-small cell lung cancer: results from a prospective multicenter observational study
by: Jie Gao, et al.
Published: (2025-03-01) -
Multimodal therapy in oligometastatic prostate cancer: A glimpse into the future?
by: Sophie Knipper, et al.
Published: (2021-04-01) -
Pathological complete response after afatinib treatment of stage IV oligometastatic adenocarcinoma of the lung: the role of pulmonary surgery
by: Ping-Chung Tsai, et al.
Published: (2019-11-01)